HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jean Rommelaere Selected Research

Peroxisome Proliferator-Activated Receptors (PPAR)

12/2017Cell death and restoration of TRAIL-sensitivity by ciglitazone in resistant cervical cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jean Rommelaere Research Topics

Disease

52Neoplasms (Cancer)
10/2021 - 05/2002
33Infections
02/2022 - 05/2002
9Glioma (Gliomas)
01/2016 - 03/2004
7Adenocarcinoma
10/2021 - 04/2010
6Virus Diseases (Viral Diseases)
02/2022 - 03/2004
6Pancreatic Neoplasms (Pancreatic Cancer)
08/2017 - 01/2009
6Neoplasm Metastasis (Metastasis)
08/2017 - 05/2002
4Parvoviridae Infections (Parvovirus Infection)
02/2022 - 06/2009
4Hepatocellular Carcinoma (Hepatoma)
10/2021 - 02/2005
4Brain Neoplasms (Brain Tumor)
01/2020 - 08/2010
4Melanoma (Melanoma, Malignant)
01/2019 - 02/2004
2Glioblastoma (Glioblastoma Multiforme)
01/2020 - 12/2017
2Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2017 - 10/2010
2Carcinoma (Carcinomatosis)
07/2013 - 10/2010
2Stomach Neoplasms (Stomach Cancer)
07/2012 - 01/2005
2Liposarcoma
12/2008 - 08/2006
2Wiskott-Aldrich Syndrome
08/2008 - 01/2005
2Hemangiosarcoma (Angiosarcoma)
02/2004 - 05/2002
1Vesicular Stomatitis
01/2021
1Vaccinia
01/2021
1Measles
01/2021
1Osteosarcoma (Osteogenic Sarcoma)
10/2017
1Disease Progression
08/2017
1Leukemia
01/2017
1Kaposi Sarcoma (Kaposi's Sarcoma)
01/2017
1Hyperplasia
02/2015
1Herpes Simplex
01/2014
1Peritoneal Neoplasms
11/2011

Drug/Important Bio-Agent (IBA)

21Proteins (Proteins, Gene)FDA Link
02/2022 - 10/2002
9Antineoplastic Agents (Antineoplastics)IBA
01/2016 - 08/2005
6Pharmaceutical PreparationsIBA
08/2017 - 01/2009
5DNA (Deoxyribonucleic Acid)IBA
08/2010 - 02/2004
4Viral ProteinsIBA
01/2018 - 09/2006
4LigandsIBA
12/2017 - 02/2011
4ChemokinesIBA
01/2017 - 05/2002
3Antiviral Agents (Antivirals)IBA
01/2021 - 01/2010
3Therapeutic UsesIBA
12/2017 - 05/2004
3Viral DNAIBA
10/2017 - 03/2003
3GemcitabineFDA Link
05/2014 - 01/2009
3CytokinesIBA
01/2014 - 05/2002
3Interleukin-2 (IL2)IBA
11/2012 - 12/2002
3Neutralizing AntibodiesIBA
01/2010 - 05/2004
2Peptides (Polypeptides)IBA
02/2022 - 04/2012
2Nucleic AcidsIBA
10/2021 - 01/2020
2Immune Checkpoint InhibitorsIBA
01/2021 - 01/2019
2Cathepsin BIBA
12/2017 - 04/2007
2AntibodiesIBA
01/2014 - 11/2011
2Histone Deacetylase InhibitorsIBA
10/2013 - 10/2010
2InterferonsIBA
11/2011 - 09/2006
2GelsolinIBA
08/2008 - 01/2005
2VaccinesIBA
06/2008 - 06/2007
1Monoclonal AntibodiesIBA
02/2022
1RNA (Ribonucleic Acid)IBA
01/2021
1ParaffinIBA
01/2020
1Single-Stranded DNA (DNA, Single Stranded)IBA
01/2020
1Messenger RNA (mRNA)IBA
01/2020
1Formaldehyde (Formol)FDA Link
01/2020
1Immune Checkpoint ProteinsIBA
01/2019
1Granzymes (Granzyme)IBA
01/2019
1IpilimumabIBA
01/2019
1NivolumabIBA
01/2019
1Nitric Oxide (Nitrogen Monoxide)FDA Link
12/2017
1Nitric Oxide Synthase (NO Synthase)IBA
12/2017
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
12/2017
1ciglitazoneIBA
12/2017
1Death Domain ReceptorsIBA
12/2017
1CaspasesIBA
12/2017
1TNF-Related Apoptosis-Inducing LigandIBA
12/2017
1TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
12/2017
1ThiazolidinedionesIBA
12/2017
1Rosiglitazone (Avandia)FDA Link
12/2017
1Pioglitazone (Actos)FDA Link
12/2017
1Gentian Violet (Violet, Crystal)FDA Link
10/2017
1Codon (Codons)IBA
11/2016
1Vaccine AdjuvantsIBA
08/2015
1cyclonite (RDX)IBA
03/2015
1CalreticulinIBA
05/2014
1AlarminsIBA
05/2014
1Adenosine Triphosphate (ATP)IBA
05/2014
1HMGB1 Protein (HMG1)IBA
05/2014
1AntigensIBA
01/2014
1Neoplasm Antigens (Tumor Antigens)IBA
01/2014
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2013
1Valproic Acid (Depakote)FDA LinkGeneric
10/2013
1LuciferasesIBA
09/2013
1IntegrinsIBA
04/2012
1Interleukin-6 (Interleukin 6)IBA
10/2011
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2011
1Biological ProductsIBA
10/2011
17-hydroxystaurosporine (UCN 01)IBA
10/2010

Therapy/Procedure

28Therapeutics
10/2021 - 05/2002
11Oncolytic Virotherapy
01/2019 - 08/2010
5Drug Therapy (Chemotherapy)
08/2017 - 02/2011
4Immunotherapy
01/2021 - 01/2015
3Radiotherapy
02/2016 - 06/2007
3Injections
02/2015 - 03/2007
2Intravenous Infusions
12/2017 - 08/2017
1Aftercare (After-Treatment)
12/2017
1Investigational Therapies (Experimental Therapy)
01/2015
1Intravenous Injections
01/2014